Literature DB >> 9315846

Exosites determine macromolecular substrate recognition by prothrombinase.

S Krishnaswamy1, A Betz.   

Abstract

The prothrombinase complex, composed of factor Xa and factor Va assembled on a membrane surface, catalyzes the proteolytic formation of thrombin during blood coagulation. The molecular basis for the macromolecular substrate specificity of prothrombinase is poorly understood. By kinetic studies of prethrombin 2 cleavage by prothrombinase in the presence or absence of fragment 1.2, we show that occupation of the active site of the catalyst by inhibitors or alternate peptidyl substrates does not alter the affinity for prethrombin 2. Productive recognition of the macromolecular substrate therefore results from an initial interaction at enzymic sites (exosites) distinct from the active site, which largely determines substrate affinity. This interaction at exosites is evident even in the absence of activation peptide domains responsible for mediating the binding of the substrate to membranes or factor Va. Interactions at the active site with structures surrounding the scissile bond then precede bond cleavage and product release. The second binding step, which appears unfavorable, does not affect substrate affinity but contributes to the maximum catalytic rate. Therefore, binding specificity of prothrombinase for the macromolecular substrate is determined by exosites on the enzyme. We show that competitive inhibition of prethrombin 2 cleavage can be accomplished by interfering with the exosite binding step without obscuring the active site of the enzyme. These findings suggest limitations to the common approach of inferring the basis of factor Xa specificity with active site mutants or the targeting the active site of factor Xa with reversible inhibitors for therapeutic purposes. The achievement of distinctive macromolecular substrate specificities through exosite interactions and modulation of maximum catalytic rate through binding steps may also underlie the reactions catalyzed by the other coagulation complexes containing trypsin-like enzymes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315846     DOI: 10.1021/bi970979+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.

Authors:  Mariola M Marcinkiewicz; Dipali Sinha; Peter N Walsh
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

2.  Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.

Authors:  Taketoshi Ogawa; Ingrid M Verhamme; Mao-Fu Sun; Paul E Bock; David Gailani
Journal:  J Biol Chem       Date:  2005-04-13       Impact factor: 5.157

3.  Ixolaris: a factor Xa heparin-binding exosite inhibitor.

Authors:  Robson Q Monteiro; Alireza R Rezaie; José M C Ribeiro; Ivo M B Francischetti
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

4.  Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

5.  Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase.

Authors:  Ayse Hacisalihoglu; Peter Panizzi; Paul E Bock; Rodney M Camire; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

Review 6.  The transition of prothrombin to thrombin.

Authors:  S Krishnaswamy
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

7.  Exosite binding drives substrate affinity for the activation of coagulation factor X by the intrinsic Xase complex.

Authors:  Manjunath Goolyam Basavaraj; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2020-08-28       Impact factor: 5.157

Review 8.  Mechanistic enzymology in drug discovery: a fresh perspective.

Authors:  Geoffrey A Holdgate; Thomas D Meek; Rachel L Grimley
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

9.  A dimeric form of prothrombin on membrane surfaces.

Authors:  P J Anderson
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

10.  Fate of membrane-bound reactants and products during the activation of human prothrombin by prothrombinase.

Authors:  Parvathi Kamath; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.